Results 11 to 20 of about 66,924 (257)
The history of solid organ transplantation is traced from its beginnings in the 19th century to the beginning of the 21st century. Surgical techniques, advances in immunology, and a review of major immunosuppressive milestones are reviewed. Over the last 50 years, transplantation has moved from experimental to accepted clinical therapy.
M K Davies, Hollman A
openaire +7 more sources
Myelofibrosis: to transplant or not to transplant? [PDF]
Abstract Hematopoietic cell transplantation (HCT) is the only curative therapeutic modality for myelofibrosis (MF) at present. The optimal timing of HCT is not known in the presence of wider availability of less risky nontransplant therapies such as JAK 1/2 inhibitors. Careful review of patient, disease, and transplant-related factors is
Vikas Gupta, Rebecca Devlin
openaire +3 more sources
Continued discussion over organ allocation and distribution remained a focal point in the field of liver transplantation in the year 2000. Despite the ongoing debate, no significant changes were implemented in the current allocation system. By far, the most widely discussed topic in liver transplantation this year was live donor adult-to-adult liver ...
Brown, KA, Moonka, DK
openaire +6 more sources
Abstract Glutathione S‐transferase theta 1 (GSTT1) is an enzyme involved in phase II biotransformation processes and a member of a multigene family of detoxifying and clearing reactive oxygen species. GSTT1 is polymorphic like other biotransforming enzymes, allowing variability in hepatic conjugation processes.
Manuel Muro‐Perez+5 more
wiley +1 more source
To Transplant or Not to Transplant – That Is the Question [PDF]
Thousands of human ovaries have been stored for desperate cancer patients by practitioners around the world. Unfortunately, most of these ovaries were stored without a clear idea about how they could be used by the eventual survivor. Recent advances in ovarian tissue freezing and transplant technology and in the emerging area of in vitro follicle ...
Teresa K. Woodruff+2 more
openaire +3 more sources
eHealth in transplantation [PDF]
eHealth ("electronic" Health) is a new field in medicine that has the potential to change medical care, increase efficiency, and reduce costs. In this review, we analyzed the current status of eHealth in transplantation by performing a PubMed search over the last 5 years with a focus on clinical studies for post-transplant care.
Duettmann, Wiebke+10 more
openaire +4 more sources
Health‐related quality of life (HRQoL) is an important goal of therapy for patients with myelodysplastic syndromes (MDS); however, little is known about HRQoL of these patients at clinical presentation. We report HRQoL profile of newly diagnosed patients with MDS across both the the International Prognostic Scoring System (IPSS) and IPSS‐Revised (IPSS ...
Fabio Efficace+26 more
wiley +1 more source
In this paper Professor Calne pleads for a more informed approach to the problem of donor transplants, particularly in cases of kidney disease. He is concerned to inform both the medical profession and lay people. Establishing a computerized register of names and addresses of those who do not wish to have their organs used for transplantation after ...
openaire +5 more sources
Outside of North America and Europe, rate of CMV infection/disease post‐SOT is highly variable and CMV recurrence is frequent. CMV resistance and treatment‐associated adverse events, including myelosuppression, highlight unmet needs with conventional therapy.
Helio Tedesco Silva Junior+6 more
wiley +1 more source
Using a farm‐scale experiment we investigated how intraspecific variation in flowering phenology and spatial heterogeneity in floral resources affected wild plant reproduction by modifying plant–pollinator interactions at the scale of the plant individual, the local assemblage, and the interaction network of agroecological infrastructures across the ...
Audrey Labonté+12 more
wiley +1 more source